ChloraDerm is the first and only transparent film dressing containing the Chlorhexidine Advantage, a safe, colophony-and acid-free, edge-to-edge chlorhexidine matrix with effectiveness against multi-drug-resistant organisms, including MRSA for at least seven days. Image source: www.rosica.com
entrotech life sciences (ELS) recently announced the availability of FDA-Cleared ChloraDerm in a new design with a reinforced border, ideal for advanced IV catheter securement. ChloraDerm is the first and only transparent film dressing containing the Chlorhexidine Advantage, a safe, colophony-and acid-free, edge-to-edge chlorhexidine matrix with effectiveness against multi-drug-resistant organisms, including MRSA for at least seven days.
The ChloraDerm platform was recently launched by entrotech life sciences, an innovative company that is taking its expertise in life-saving products from the military battlefield to the hospital bed-side. The new design integrates a soft cloth reinforced border into the ChloraDerm dressing platform providing healthcare providers with added comfort and securement feature for IV catheter sites when more robust dressing security and stability are required for the patient.
“Both the patient and healthcare provider will benefit from ChloraDerm’s new securement offering,” said ELS CEO Jim McGuire. “Our demonstrated ability to rapidly develop and commercialize life-saving technologies is instrumental to reducing preventable infections around the globe.”
entrotech life sciences
entrotechlifesciences.com
